| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.904 | 0.002 | 0.983 | Neurokinin 1 antagonist | 0.983 0.001 DBMET01398 | DBMET01398 | |
| 0.892 | 0.002 | 0.977 | Neurokinin antagonist | 0.977 0.001 DBMET01398 | DBMET01398 | |
| 0.861 | 0.005 | 0.972 | Analgesic | 0.972 0.004 DBMET01398 | DBMET01398 | |
| 0.833 | 0.002 | 0.833 | Substance P antagonist | 0.734 0.002 DBMET01398 | ||
| 0.544 | 0.014 | 0.544 | Calcium channel L-type activator | 0.483 0.035 DBMET01398 | ||
| 0.482 | 0.095 | 0.482 | Antiinflammatory | 0.334 0.185 DBMET01398 | ||
| 0.421 | 0.052 | 0.421 | Toll-Like receptor 7 agonist | |||
| 0.413 | 0.055 | 0.413 | Toll-Like receptor agonist | |||
| 0.378 | 0.074 | 0.378 | Antiobesity | 0.221 0.186 DBMET01398 | ||
| 0.291 | 0.101 | 0.291 | Calcium channel activator | 0.216 0.19 DBMET01398 | ||
| 0.217 | 0.027 | 0.217 | Sodium channel blocker | |||
| 0.213 | 0.025 | 0.213 | Sodium channel (voltage-gated) blocker | |||
| 0.235 | 0.063 | 0.235 | Anticonvulsant | |||
| 0.307 | 0.157 | 0.307 | Cyclophilin D inhibitor | |||
| 0.14 | 0.018 | 0.14 | MAP-kinase-activated kinase inhibitor | 0.102 0.037 DBMET01398 | ||
| 0.131 | 0.016 | 0.131 | MAP-kinase-activated kinase 2 inhibitor | 0.093 0.033 DBMET01398 | ||
| 0.138 | 0.026 | 0.138 | Acetylcholine M3 receptor agonist | 0.092 0.05 DBMET01398 | ||
| 0.197 | 0.095 | 0.197 | Potassium channel blocker | |||
| 0.151 | 0.059 | 0.151 | MAP3K9 inhibitor | 0.129 0.097 DBMET01398 | ||
| 0.128 | 0.046 | 0.128 | CDK3/cyclin E inhibitor | 0.108 0.074 DBMET01398 | ||
| 0.224 | 0.151 | 0.224 | Interleukin 2 agonist | 0.221 0.155 DBMET01398 | ||
| 0.076 | 0.005 | 0.076 | Acetyl-CoA carboxylase 1 inhibitor | 0.037 0.007 DBMET01398 | ||
| 0.121 | 0.053 | 0.121 | Nav1.5 sodium channel blocker | |||
| 0.076 | 0.009 | 0.076 | Glycine transporter 1 inhibitor | 0.042 0.019 DBMET01398 | ||
| 0.071 | 0.011 | 0.071 | Acetyl-CoA carboxylase inhibitor | 0.05 0.02 DBMET01398 | ||
| 0.118 | 0.06 | 0.118 | Alpha 2b adrenoreceptor antagonist | |||
| 0.042 | 0.009 | 0.042 | Acetyl-CoA carboxylase 2 inhibitor | 0.021 0.016 DBMET01398 | ||
| 0.048 | 0.017 | 0.048 | Kinesin-like protein 1 inhibitor | |||
| 0.048 | 0.017 | 0.048 | Kinesin antagonist | |||
| 0.083 | 0.054 | 0.083 | Thioredoxin reductase inhibitor | 0.077 0.072 DBMET01398 | ||
| 0.132 | 0.11 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.138 0.082 DBMET01398 | DBMET01398 | |
| 0.086 | 0.065 | 0.086 | Antiadrenergic | |||
| 0.085 | 0.064 | 0.085 | Adrenaline antagonist | |||
| 0.019 | 0.008 | 0.019 | Calcium-sensing receptor antagonist | 0.014 0.012 DBMET01398 | ||
| 0.04 | 0.03 | 0.04 | Neurokinin 2 antagonist | |||
| 0.019 | 0.013 | 0.019 | Endothelin B receptor antagonist | |||
| 0.005 | 0.062 | 0.085 | Nociceptin (N/OFQ) receptor agonist | 0.085 0.004 DBMET01398 | DBMET01398 | |
| 0.119 | 0.309 | 0.169 | Peptidyltransferase inhibitor | 0.169 0.149 DBMET01398 | DBMET01398 | |
| 0.015 | 0.375 | 0.083 | Analgesic, opioid | 0.083 0.044 DBMET01398 | DBMET01398 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |